Industrial glucoamylase for brewers targeting higher attenuation, drier finish, lower residual dextrins, and more consistent fermentable sugar release in selected beer styles.
Request pricingSacchera glucoamylase helps brewers convert residual dextrins into fermentable glucose, supporting higher attenuation, a drier sensory profile, and tighter control of carbohydrate contribution in selected beer programs.
For process teams, the value is practical: more complete fermentable sugar release, improved consistency across mash and fermentation variables, and a clearer route to beer styles where residual sweetness, body, or carbohydrate load must be deliberately reduced.
Glucoamylase, also known as amyloglucosidase or glucan 1,4-alpha-glucosidase, works from the non-reducing ends of starch-derived chains and dextrins, releasing glucose that yeast can ferment. In brewing, this makes it useful when native malt enzymes or standard mash profiles leave too much limit dextrin behind.
Common use cases include:
Sacchera is intended for commercial brewing teams that need technical flexibility without vague enzyme claims.
By converting dextrins into glucose, glucoamylase can help yeast ferment a larger share of the available carbohydrate pool. This is especially relevant where a beer specification calls for a dry finish, reduced residual extract, or a tighter final gravity target.
Glucoamylase gives formulation teams another control point for carbohydrate profile. It does not replace recipe design, mash control, or yeast selection, but it can extend fermentability beyond what standard mashing alone may deliver.
Malt modification, adjunct quality, grist composition, and mash performance can all affect fermentability. A validated glucoamylase addition strategy can reduce batch-to-batch variation in residual dextrin load and support more predictable attenuation.
Depending on the selected grade and process design, glucoamylase may be evaluated for addition during mashing, wort handling, or fermentation. The right placement depends on temperature exposure, pH, residence time, yeast strategy, alcohol tolerance, and the target beer profile.
Glucoamylase is powerful. In brewing, that is an advantage only when it is controlled.
Review these points during trials:
Mash-stage use can support enhanced conversion where brewers want to increase fermentable extract before wort separation. This approach is often evaluated in adjunct-heavy or high-fermentability designs. It requires attention to mash temperature, hold time, pH, and interaction with existing malt enzymes.
Fermentation-stage use may help reduce residual dextrins after wort production. This can be useful for high-attenuation targets, but it also requires careful monitoring because enzyme activity can continue to affect gravity and dryness during fermentation and conditioning.
Sacchera recommends bench or pilot trials before production adoption. The objective is not simply “more enzyme.” The objective is the correct attenuation curve, finished beer balance, and repeatable process behavior.
To help Sacchera recommend the appropriate commercial grade, include:
Sacchera glucoamylase is supplied for industrial brewing and beverage production environments where consistency, documentation, and application support matter. Available documentation may include product specification, ingredient status, recommended storage conditions, allergen or dietary statements where applicable, and regional compliance information relevant to the supplied grade.
For procurement teams, Sacchera supports quote requests with packaging options, lead time information, and commercial supply discussion. For technical teams, we support application conversations focused on process fit and trial design.
Tell us what you are brewing, where you plan to add glucoamylase, and what attenuation target you need to reach. Sacchera will respond with grade guidance, pricing, and next-step trial recommendations.
No. It is best used when higher attenuation, dryness, or reduced residual dextrin is a defined target. It can reduce body if applied to beers where malt fullness is part of the intended profile.
Yes, glucoamylase is commonly evaluated in processes where adjuncts or starch-derived materials affect fermentability. The full enzyme system should be considered alongside liquefaction, saccharification, mash profile, and yeast selection.
Both positions can be evaluated, but they produce different control dynamics. Mash addition is often easier to integrate with brewhouse conversion logic, while fermentation addition can extend attenuation after wort production. The best option depends on process constraints and finished beer targets.
Yes. Share your process window and target profile, and Sacchera can help structure a practical trial plan for commercial evaluation.



Tell us your application and volume — we reply with pricing and lead time.